Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Published in Rheumatology (Oxford)

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
InvestorsHub on MSN

Soligenix shares jump on encouraging data for Behçet’s disease therapy

Soligenix Inc (NASDAQ:SNGX) shares rose 5.2% on Thursday after the company released positive findings from a Phase 2a ...
Healio

Study: No benefit from anticoagulant use in Behçet’s disease

Patients with vascular manifestations of Behçet’s disease who received treatment with anticoagulants did not benefit from the therapy given in addition to immunosuppressant drugs, according to results ...
Clinical Trials Arena on MSN

Soligenix reports Phase IIa SGX945 trial data for Behçet’s disease

Soligenix has reported positive data from its Phase IIa trial of SGX945 (dusquetide) for the treatment of Behçet's disease.
Medindia

Medications and Drugs for Treatment of Behcet's Syndrome

Find effective medications for 'Behcet's Syndrome treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage ...
Yahoo Finance

Behcet’s Disease Treatment Market will reach to USD 29.44 million by 2029 : GreyViews

Pune India, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East and ...
Healio

Behcet's disease remains largely unknown among physicians

Please provide your email address to receive an email when new articles are posted on . The rare and complex Behcet’s disease is often misdiagnosed or undiagnosed, leading to significant, but ...
Business Wire

Behcet's Syndrome | A Pipeline Analysis Report 2018 | Technavio

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the Behcet's syndrome market. The report includes a detailed analysis of the pipeline molecules under ...
The New England Journal of Medicine

Behçet’s Syndrome

Neutrophils constitute the main infiltrating cell type in Behçet’s syndrome lesions. By producing excessive levels of reactive oxygen species and releasing neutrophil extracellular traps, neutrophils ...
MedPage Today

Stelara: A New Option in Behcet's?

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The monoclonal ...
Nature

Behçet's syndrome: disease manifestations, management, and advances in treatment

The acne lesions characteristic of Behçet's syndrome are not sterile and are commonly observed in combination with arthritis. The two main nodular skin lesions—superficial thrombophlebitis and ...